Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001367644-24-000180
Filing Date
2024-11-12
Accepted
2024-11-12 16:26:14
Documents
4
Period of Report
2024-10-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1731446762.html 3  
1 FORM 3 wk-form3_1731446762.xml 3 4606
2 EX-24 perlpoasigned2024.htm EX-24 907
3 perlpoasigned2024001.jpg GRAPHIC 224199
4 perlpoasigned2024002.jpg GRAPHIC 124736
  Complete submission text file 0001367644-24-000180.txt   487682
Mailing Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879
Business Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Issuer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 300 PROFESSIONAL DRIVE GAITHERSBURG MD 20879
Business Address
Perl Jessica (Reporting) CIK: 0002043716 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33137 | Film No.: 241448722